GAIN THERAPEUTICS INC. - COMMON STOCK

Gain Therapeutics to Participate in the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

26 Apr 2022 16:18:58 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Data on its Small Molecule Lead Compound in GBA1 Parkinson’s Disease at the 2022 Synuclein Meeting

12 Apr 2022 12:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Additional Confirmatory Data on its Gaucher Disease Program at the 2022 Glycolipid and Sphingolipid Biology Gordon Research Conference

29 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Full Year 2021 Financial Results and Business Update

24 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Data on its Structurally Targeted Allosteric Regulators in both Parkinson’s and Alzheimer’s Disease at the AD/PD 2022 Conference

15 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Participation in Upcoming Investor and Scientific Conferences

01 Mar 2022 07:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Preclinical Data on its Structurally Targeted Allosteric Regulators in GBA1 Gaucher Disease at the WORLDSymposium 2022

08 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics Outlines Key Objectives for 2022 Following its Inaugural R&D Day

04 Feb 2022 11:06:54 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Additional Details on its February 4th Virtual R&D Day

31 Jan 2022 15:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics Announces R&D Day Event and Participation in Upcoming Conferences

18 Jan 2022 07:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the H.C. Wainwright Bioconnect Virtual Conference

06 Jan 2022 15:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 Dec 2021 15:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics Progresses Krabbe Disease Program and Provides Scientific Update

07 Dec 2021 07:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the Imagine AI + Healthcare Investor Summit

01 Dec 2021 15:07:42 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial Results and Business Update

12 Nov 2021 06:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Parkinson’s Disease Preclinical Study Results at Society for Neuroscience Annual Meeting

11 Nov 2021 10:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Breakthrough Pre-Clinical Data of Novel Small Molecules for the Treatment of Parkinson’s Disease and Gaucher Disease

10 Nov 2021 10:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at the 12th Annual Jefferies London Healthcare Conference

04 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at Upcoming Medical Conferences

28 Oct 2021 07:00:03 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Announces Appointment of Five Members to its Newly Formed Scientific Advisory Board (SAB)

26 Oct 2021 07:00:02 By Nasdaq GlobeNewswire